GSK778 hydrochloride
CAS No. 2863657-79-6
GSK778 hydrochloride ( —— )
产品货号. M37654 CAS No. 2863657-79-6
GSK778 hydrochloride hydrochloride is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. GSK778 hydrochloride hydrochloride phenocopies the effects of pan-BET inhibitors in cancer models.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1663 | 有现货 |
|
| 10MG | ¥2461 | 有现货 |
|
| 25MG | ¥3832 | 有现货 |
|
| 50MG | ¥5199 | 有现货 |
|
| 100MG | ¥6750 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥2052 | 有现货 |
|
生物学信息
-
产品名称GSK778 hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GSK778 hydrochloride hydrochloride is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. GSK778 hydrochloride hydrochloride phenocopies the effects of pan-BET inhibitors in cancer models.
-
产品描述GSK778 hydrochloride hydrochloride is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. GSK778 hydrochloride hydrochloride phenocopies the effects of pan-BET inhibitors in cancer models.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Chromatin/Epigenetic
-
靶点Epigenetic Reader Domain
-
受体Epigenetic Reader Domain
-
研究领域——
-
适应症——
化学信息
-
CAS Number2863657-79-6
-
分子量548.08
-
分子式C30H34ClN5O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC[C@@H](N1C(COC)=NC2=C1C3=CC(OC[C@@H]4CNCC4)=C(C5=C(C)ON=C5C)C=C3N=C2)C6=CC=CC=C6.[H]Cl
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
CREB inhibitor
666-15 是一种有效的选择性 CREB 抑制剂 (IC50: 81 nM)。
-
Escitalopram Oxalate
Escitalopram Oxalate 是一种选择性血清素 (5-HT) 再摄取抑制剂 (SSRI),Ki 为 0.89 nM。
-
DC-BPi-03
DC-BPi-03 是一种有效的 BPTF-BRD 抑制剂,IC50 为 698.3 nM,Kd 为 2.81 μM。
021-51111890
购物车()
sales@molnova.cn

